Today: 10 June 2026
Browse Category

NYSE:MKC 12 November 2025 - 16 May 2026

McCormick Shares Fall Again — Monday Seen as Key for Unilever Deal Impact

McCormick Shares Fall Again — Monday Seen as Key for Unilever Deal Impact

McCormick closed Friday at $46.35, down 0.34%, after touching a week low of $44.82 amid investor focus on its planned merger with Unilever Foods. The deal, using a Reverse Morris Trust, would give Unilever 65% of the combined company and $15.7 billion in cash. The NYSE is closed for the weekend, with trading set to resume Monday. The S&P 500 fell 1.2% Friday as oil prices rose.
16 May 2026
···
McCormick stock tumbles as MKC flags tariff costs and a softer 2026 profit outlook

McCormick stock tumbles as MKC flags tariff costs and a softer 2026 profit outlook

McCormick shares fell 7.9% to $61.27 after the company’s 2026 profit forecast missed Wall Street estimates and management warned of continued tariff and commodity cost pressures. Fourth-quarter adjusted earnings were 86 cents per share on $1.85 billion in sales. The company expects 2026 adjusted EPS of $3.05 to $3.13 and sales growth of 13% to 17%. Rivals Kraft Heinz, General Mills, and Conagra rose.
22 January 2026
··

Stock Market Today

  • BIO-key Receives Nasdaq Notice for Delayed 10-Q Filing
    June 10, 2026, 5:45 PM EDT. BIO-key International, Inc. (OTC: BKYI) received a non-compliance notice from Nasdaq for failing to file its Quarterly Report on Form 10-Q for Q1 2026 on time as required by Nasdaq Listing Rule 5250(c)(1). Nasdaq's notification states the company's delay could affect its continued listing on the Nasdaq Capital Market pending a Hearing Panel determination. BIO-key specializes in biometric authentication and identity access management (IAM) technologies. The company serves over 40 million users with its cloud-hosted and on-premise PortalGuard IAM solution, supporting secure, multi-factor authentication options including passwordless methods. This regulatory development adds pressure on BIO-key to meet reporting requirements amid its efforts to secure market confidence.

Latest articles

Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Snap Inc. Targets Health Ad Dollars With New Snapchat Study as Pressure Builds

Snap Shares Drop Again With Tech Names Under Pressure

10 June 2026
Snap Inc. shares slid 4% to $5.38, extending a three-day losing streak and deepening doubts about its turnaround despite improved cash flow and cost cuts, as investors await CEO Evan Spiegel’s June 16 AWE keynote and weigh weak ad growth, falling eCPMs, and ongoing macro and regulatory risks.
Go toTop